Weihai Lotus also has a growing business of importing narcotic API’s such as Dihydrocodeine, Morphine, Oxycodone and Hydrocodone from Europe and the US which it uses for its own production and sells to licensed formulation companies in China. A first in China. In successfully applying for these unique import licenses, the company has built a proven capability of registering narcotic products and in doing so, has developed an excellent professional working relationship with the China Food and Drug Administration.
The company was one of the first to be certified by the CFDA as cGMP compliant. Certification being valid for five years the company has since successfully undergone three further inspections. The Weihai site occupies an area of four acres and includes pharmaceutical production, office buildings, warehousing and analytical and product development laboratories with a total built up area of 13,000 m². By carefully selecting locally produced equipment and importing some of the main production equipment the right blend of cost containment, high product quality and reliability has been achieved.